- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06886841
Parental Well-being After Childbirth in Switzerland (SOCRATES)
Stress of Co-parents Related to a Traumatic Experience of Birth Across Switzerland
Improving maternal and child health is a global priority, with increasing emphasis on ensuring women and their families not only survive but also thrive after childbirth. While high-income countries like Switzerland provide strong antenatal and intrapartum care, the quality of postnatal care often lags behind, despite the critical physical, mental, and social needs of the postpartum period. Studies indicate high rates of mental distress, physical pain, and sexual discomfort among mothers, alongside a lack of research on the well-being of co-parents.
The main question this cohort study aims to answer is: how do the health and well-being of mothers and co-parents evolve during the first year after childbirth? Participants will complete four online questionnaires: the first within the first few days after birth, followed by additional assessments at 2, 6, and 12 months postpartum.
This comprehensive approach seeks to inform policy and improve evidence-based postnatal care practices, benefiting approximately 80,000 families annually in Switzerland.
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Laurent GAUCHER, PhD
- Phone Number: +41 22 558 68 96
- Email: laurent.gaucher@hesge.ch
Study Contact Backup
- Name: Elsa Lorthe, PhD
- Phone Number: +41 22 558 79 54
- Email: elsa.lorthe@hesge.ch
Study Locations
-
-
-
Geneva, Switzerland, 1206
- Recruiting
- Haute Ecole de Santé Genève
-
Contact:
- Laurent Gaucher, RM, PhD
- Phone Number: +41 22 558 68 96
- Email: laurent.gaucher@hesge.ch
-
Contact:
- Elsa Lorthe, RM, PhD
- Email: elsa.lorthe@hesge.ch
-
Contact:
- Laurent Gaucher, RM, PhD
-
Winterthur, Switzerland
- Recruiting
- ZHAW Zurich University of Applied Sciences
-
Contact:
- Susanne Grylka, RM, PhD
- Phone Number: +41 58 934 43 77
- Email: susanne.grylka@zhaw.ch
-
Contact:
- Susanne Grylka, RM, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion criteria:
- Women who give birth in a participating maternity unit or birth center during the study period.
- Partner of a participating women: the partner must be designated by the mother, live with her at the time of birth, and only one partner can be included per mother.
- Gestational age at birth: ≥22+0 weeks and/or birthweight ≥500 grams
- Age: Participants must be 14 years or older.
- Language Proficiency: Participants must have sufficient proficiency in one of Switzerland's main official languages (German, French, Italian) or English to ensure accurate communication and comprehension of study materials.
Exclusion Criteria:
- Refusal to participate
- Inability to provide informed consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Childbirth-related post-traumatic stress disorder
Time Frame: 2 months postpartum
|
The prevalence of childbirth-related post-traumatic stress disorder in both parents will be assessed using the validated City Birth Trauma Scale (City BiTS).
This self-reported questionnaire consists of 29 items, 20 of which measure the frequency of trauma symptoms, including intrusive thoughts, avoidance, negative mood, and hyperarousal, based on the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).
Items are rated using a four-point Likert-type scale, ranging from 0 to 3. The total score varies from 0 to 60 points, with higher scores indicating a higher level of PTSD-symptoms.
|
2 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postpartum depression and anxiety
Time Frame: At birth, and at 2, 6, and 12 months postpartum
|
Postpartum depression and anxiety will be assessed in both parents, using the Edinburgh Postnatal Depression Scale (EPDS) at birth, and at 2, 6, and 12 months postpartum.
This validated 10-item questionnaire screens for symptoms of depression and anxiety.
Responses are rated on a four-point Likert scale, ranging from 0 to 3. The total score ranges from 0 to 30 points, with higher scores indicating a greater risk of depression.
|
At birth, and at 2, 6, and 12 months postpartum
|
|
Health-related quality of life
Time Frame: At birth, and at 2, 6, and 12 months postpartum
|
Assessed in both parents with the EuroQoL 5-Dimension 5-Level scale (EQ-5D-5L), along with a visual analogue scale for self-rated health (EQ VAS).
The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions.
This decision results in a 1-digit number that expresses the level selected for that dimension.
The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
The EQ VAS records the patient's self-rated health on a visual analogue scale ranging from 0 to 100 where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.
|
At birth, and at 2, 6, and 12 months postpartum
|
|
Physical recovery
Time Frame: At birth (Obstetric Quality of Recovery-10), and at 2, 6, and 12 months postpartum (pain and incontinence)
|
Mothers' quality of recovery after childbirth, will be assessed using the Obstetric Quality of Recovery-10 (ObsQoR-10) tool.
This validated, self-reported measure evaluates pain, physical symptoms, mobility, self-care, and baby care on an 11-point scale ranging from 0 (worst outcome) to 10 (best outcome).
The total score ranges from 0 to 100, with higher scores indicating better recovery quality.
Additional dimensions, in particular pain and incontinence, will also be evaluated in mothers.
|
At birth (Obstetric Quality of Recovery-10), and at 2, 6, and 12 months postpartum (pain and incontinence)
|
|
Sexual health
Time Frame: 6 and 12 months postpartum
|
Assessed at 6 and 12 months postpartum in mothers using the Female Sexual Function Index (FSFI-6), a validated questionnaire that can be used to screen for sexual dysfunction in women.
It consists of 6 items covering 6 domains (desire, arousal, lubrication, orgasm, satisfaction, and pain).
Each item of the FSFI-6 questionnaire is associated with a 5-point ordinal scale, in which 5 represents optimal function and 1 the poorest function.
The scores for each domain are summed to provide a total score, with a higher score indicating better sexual function.
|
6 and 12 months postpartum
|
|
Hospitalisations
Time Frame: From one year before to one year after childbirth
|
Collected through linkage with the "Medical Statistics of Hospitals" database, this outcome includes the frequency, reasons, and costs of hospitalisations from one year before to one year after childbirth.
This data provides critical insights into severe health outcomes and rehospitalisations in mothers and infants.
|
From one year before to one year after childbirth
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laurent Gaucher, RM, PhD, Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- G700026130408
- 220494 (Other Grant/Funding Number: Swiss National Science Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway